Endurant Capital Management
Latest statistics and disclosures from Endurant Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BSX, TMO, AXNX, ELV, ICLR, and represent 46.42% of Endurant Capital Management's stock portfolio.
- Added to shares of these 9 stocks: AXNX, ICLR, LH, EHC, PFE, A, FTRE, QGEN, ACRS.
- Started 9 new stock positions in ACRS, A, EHC, PFE, AXNX, FTRE, ICLR, LH, QGEN.
- Reduced shares in these 10 stocks: BMRN (-$17M), BRKR (-$6.9M), AZN (-$6.5M), TMO (-$5.3M), ELV (-$5.1M), AVTR, , ARGX, CNMD, COO.
- Sold out of its positions in ABT, ADAP, AHCO, ACLX, ARGX, AZN, AXSM, BLUE, AZTA, BRKR.
- Endurant Capital Management was a net seller of stock by $-99M.
- Endurant Capital Management has $17M in assets under management (AUM), dropping by -84.34%.
- Central Index Key (CIK): 0001633055
Tip: Access up to 7 years of quarterly data
Positions held by Endurant Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 25 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Boston Scientific Corporation (BSX) | 13.0 | $2.3M | -18% | 39k | 57.81 |
|
Thermo Fisher Scientific (TMO) | 11.5 | $2.0M | -72% | 3.8k | 530.79 |
|
Axonics Modulation Technolog (AXNX) | 8.9 | $1.5M | NEW | 25k | 62.23 |
|
Anthem (ELV) | 7.1 | $1.2M | -80% | 2.6k | 471.56 |
|
Icon SHS (ICLR) | 5.9 | $1.0M | NEW | 3.7k | 283.07 |
|
Laboratory Corp Amer Hldgs Com New (LH) | 5.2 | $906k | NEW | 4.0k | 227.29 |
|
Encompass Health Corp (EHC) | 4.9 | $859k | NEW | 13k | 66.72 |
|
Insulet Corporation (PODD) | 4.9 | $848k | -56% | 3.9k | 216.98 |
|
Hologic (HOLX) | 4.8 | $831k | -34% | 12k | 71.45 |
|
Zimmer Holdings (ZBH) | 3.9 | $687k | -67% | 5.6k | 121.70 |
|
Avantor (AVTR) | 3.2 | $562k | -89% | 25k | 22.83 |
|
Tenet Healthcare Corp Com New (THC) | 3.2 | $552k | -73% | 7.3k | 75.57 |
|
Pfizer (PFE) | 2.6 | $455k | NEW | 16k | 28.79 |
|
BioMarin Pharmaceutical (BMRN) | 2.6 | $448k | -97% | 4.7k | 96.42 |
|
Orthopediatrics Corp. (KIDS) | 2.5 | $437k | -80% | 13k | 32.51 |
|
Cigna Corp (CI) | 2.4 | $414k | -77% | 1.4k | 299.45 |
|
Quidel Corp (QDEL) | 2.2 | $379k | -80% | 5.1k | 73.70 |
|
Cooper Cos Com New (COO) | 2.1 | $374k | -91% | 988.00 | 378.44 |
|
Sabra Health Care REIT (SBRA) | 1.6 | $286k | -90% | 20k | 14.27 |
|
Agilent Technologies Inc C ommon (A) | 1.5 | $264k | NEW | 1.9k | 139.03 |
|
Fortrea Hldgs Common Stock (FTRE) | 1.4 | $244k | NEW | 7.0k | 34.90 |
|
Qiagen Nv Shs New (QGEN) | 1.3 | $227k | NEW | 5.2k | 43.43 |
|
Humana (HUM) | 1.2 | $215k | -92% | 469.00 | 457.81 |
|
AmerisourceBergen (COR) | 1.2 | $203k | -91% | 990.00 | 205.38 |
|
Aclaris Therapeutics (ACRS) | 0.9 | $156k | NEW | 148k | 1.05 |
|
Past Filings by Endurant Capital Management
SEC 13F filings are viewable for Endurant Capital Management going back to 2014
- Endurant Capital Management 2023 Q4 filed Feb. 14, 2024
- Endurant Capital Management 2023 Q3 filed Nov. 14, 2023
- Endurant Capital Management 2023 Q2 filed Aug. 14, 2023
- Endurant Capital Management 2023 Q1 filed May 15, 2023
- Endurant Capital Management 2022 Q4 filed Feb. 14, 2023
- Endurant Capital Management 2022 Q3 filed Nov. 14, 2022
- Endurant Capital Management 2022 Q2 filed Aug. 15, 2022
- Endurant Capital Management 2022 Q1 filed May 16, 2022
- Endurant Capital Management 2021 Q4 filed Feb. 14, 2022
- Endurant Capital Management 2021 Q3 filed Nov. 15, 2021
- Endurant Capital Management 2021 Q2 restated filed Aug. 27, 2021
- Endurant Capital Management 2021 Q2 filed Aug. 16, 2021
- Endurant Capital Management 2021 Q1 filed May 17, 2021
- Endurant Capital Management 2020 Q4 filed Feb. 16, 2021
- Endurant Capital Management 2020 Q3 filed Nov. 16, 2020
- Endurant Capital Management 2020 Q2 filed Aug. 14, 2020